Additionally, the elevated levels of soluble CD40L found in both bipolar disorder and SZ indicate the change in the inflammatory system (36), which suggests that activating the CD40 signaling pathway could trigger the release of anti-inflammatory cytokines and neuroprotective factors, potentially slowing the development and progression of SZ. The gene discussed is CD40LG; the disease is bipolar disorder.